| Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality EL Fosbøl, JH Butt, L Østergaard, C Andersson, C Selmer, K Kragholm, ... Jama 324 (2), 168-177, 2020 | 432 | 2020 |
| Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER PS Jhund, T Kondo, JH Butt, KF Docherty, BL Claggett, AS Desai, ... Nature medicine 28 (9), 1956-1964, 2022 | 187 | 2022 |
| Association between male sex and outcomes of Coronavirus Disease 2019 (Covid-19)—a Danish nationwide, register-based study K Kragholm, MP Andersen, TA Gerds, JH Butt, L Østergaard, ... Clinical Infectious Diseases 73 (11), e4025-e4030, 2021 | 151 | 2021 |
| Incidence of new-onset and worsening heart failure before and after the COVID-19 epidemic lockdown in Denmark: a nationwide cohort study C Andersson, T Gerds, E Fosbøl, M Phelps, J Andersen, M Lamberts, ... Circulation: Heart Failure 13 (6), e007274, 2020 | 111 | 2020 |
| Long-term risk of infective endocarditis after transcatheter aortic valve replacement JH Butt, N Ihlemann, O De Backer, L Søndergaard, E Havers-Borgersen, ... Journal of the American College of Cardiology 73 (13), 1646-1655, 2019 | 111 | 2019 |
| Long-term thromboembolic risk in patients with postoperative atrial fibrillation after coronary artery bypass graft surgery and patients with nonvalvular atrial fibrillation JH Butt, Y Xian, ED Peterson, PS Olsen, R Rørth, A Gundlund, JB Olesen, ... JAMA cardiology 3 (5), 417-424, 2018 | 106 | 2018 |
| Risk of thromboembolism associated with atrial fibrillation following noncardiac surgery JH Butt, JB Olesen, E Havers-Borgersen, A Gundlund, C Andersson, ... Journal of the American College of Cardiology 72 (17), 2027-2036, 2018 | 105 | 2018 |
| Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: a post hoc analysis of the DAPA-HF trial JH Butt, P Dewan, B Merkely, J Belohlávek, J Drożdż, M Kitakaze, ... Annals of internal medicine 175 (6), 820-830, 2022 | 78 | 2022 |
| Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER trial JH Butt, PS Jhund, J Belohlávek, RA De Boer, CE Chiang, AS Desai, ... Circulation 146 (16), 1210-1224, 2022 | 74 | 2022 |
| Long-term adverse cardiac outcomes in patients with sarcoidosis A Yafasova, EL Fosbøl, M Schou, F Gustafsson, K Rossing, H Bundgaard, ... Journal of the American College of Cardiology 76 (7), 767-777, 2020 | 74 | 2020 |
| Endothelial function in migraine with aura–a systematic review JH Butt, U Franzmann, C Kruuse Headache: The Journal of Head and Face Pain 55 (1), 35-54, 2015 | 71 | 2015 |
| Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study JH Butt, TA Gerds, M Schou, K Kragholm, M Phelps, E Havers-Borgersen, ... BMJ open 10 (12), e044421, 2020 | 68 | 2020 |
| Readmission and death in patients admitted with new‐onset versus worsening of chronic heart failure: insights from a nationwide cohort JH Butt, EL Fosbøl, TA Gerds, C Andersson, JJV McMurray, MC Petrie, ... European journal of heart failure 22 (10), 1777-1785, 2020 | 64 | 2020 |
| All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study JH Butt, EL Fosbøl, TA Gerds, C Andersson, K Kragholm, ... European heart journal 42 (15), 1516-1523, 2021 | 60 | 2021 |
| Long-term cardiovascular outcomes in systemic lupus erythematosus A Yafasova, EL Fosbøl, M Schou, B Baslund, M Faurschou, KF Docherty, ... Journal of the American College of Cardiology 77 (14), 1717-1727, 2021 | 58 | 2021 |
| Vitamin K antagonists vs. direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillation JH Butt, O De Backer, JB Olesen, TA Gerds, E Havers-Borgersen, ... European Heart Journal-Cardiovascular Pharmacotherapy 7 (1), 11-19, 2021 | 58 | 2021 |
| Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF JH Butt, KF Docherty, PS Jhund, RA De Boer, M Böhm, AS Desai, ... European journal of heart failure 24 (3), 513-525, 2022 | 48 | 2022 |
| Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox JH Butt, MC Petrie, PS Jhund, N Sattar, AS Desai, L Køber, JL Rouleau, ... European heart journal 44 (13), 1136-1153, 2023 | 46 | 2023 |
| Long-term follow-up of DANISH (the Danish study to assess the efficacy of ICDs in patients with nonischemic systolic heart failure on mortality) A Yafasova, JH Butt, MB Elming, JC Nielsen, J Haarbo, L Videbæk, ... Circulation 145 (6), 427-436, 2022 | 42 | 2022 |
| Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA‐HF trial JH Butt, JC Nicolau, S Verma, KF Docherty, MC Petrie, SE Inzucchi, ... European journal of heart failure 23 (4), 601-613, 2021 | 42 | 2021 |
C KruuseDept. Neurology, Neurovascular Research Unit, Herlev Gentofte Hospital, University of CopenhagenVerified email at dadlnet.dk
